GGrantIndex
Sort

130,381 grants matching hiv

Allosteric Modulators of Dopamine Transporter as Therapeutic Agents for NeuroAIDS

$927,795
Corinne Elizabeth Augelli-Szafran · Southern Research Institute · R01 · FY2024 · DA

DENVER COMMUNITY PROGRAM FOR CLINICAL RESEARCH ON AIDS (

$927,675
Denver Health Medical Center · U01 · FY2002 · AI

Non-Human Primate Core

$927,631
Ivona Pandrea · University Of Pennsylvania · P01 · FY2012 · AI

Vascular macrophages and T cells in atherosclerosis

$927,585
Klaus F. Ley · La Jolla Institute For Immunology · R35 · FY2019 · HL

Topical Microbicides for Prevention of STDs/HIV

$927,387
Magee-Women'S Res Inst And Foundation · P01 · FY2002 · AI

CHICAGO'S ENHANCED COMPREHENSIVE HIV PREVENTION PLANNING INITIATIVE

$927,371
Patrick Lenihan · Chicago Ctr/Hlth Systems Development · U65 · FY2010 · PS

Early and Reinfection in High Risk Women

$927,205
Julie M Overbaugh · Fred Hutchinson Cancer Center · R01 · FY2022 · HD

IL-15 Therapy Combined with TGF-Beta Blockade for Sustained HIV Remission

$927,200
Vijayakumar Velu · Emory University · R56 · FY2024 · AI

Engineering the Immune Response of a Self-replicating and Adjuvanting RNA HIV-1Vaccine

$927,069
Amit Praful Khandhar · Hdt Bio Corporation · R61 · FY2021 · AI

Developmental Core

$927,064
Karen A Kirby · Seattle Children'S Hospital · U54 · FY2025 · AI

Inducing HIV-1 NAb Breadth by Native Trimer Prime-Boost Vaccination

$926,870
James M Binley · San Diego Biomedical Research Institute · R01 · FY2024 · AI

Production Of HIV And HIV Related Proteins For Structural Studies

$926,829
Paul T Wingfield · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2019 · AR

HIV Reservoir Ecology of Viral Remission (PTC)

$926,815
Jonathan Li · Brigham And Women'S Hospital · R01 · FY2025 · AI

Gene-Environment Interplay in the Development of Drug Abuse, HIV Sexual Risk Beha

$926,799
Karl Gordon Hill · University Of Washington · R01 · FY2013 · DA

REPRIEVE - DCC

$926,776
Udo Hoffmann · Massachusetts General Hospital · U01 · FY2018 · HL

REPRIEVE - DCC

$926,776
Michael Tse-Yin Lu · Massachusetts General Hospital · U01 · FY2019 · HL

Transmission Of Tuberculosis Among illicit drug use Linkages (TOTAL)

$926,757
Karen R Jacobson · Boston Medical Center · R01 · FY2023 · AI

Pediatric AIDS Clinical Trials Unit

$926,698
Ram Yogev · Lurie Children'S Hospital Of Chicago · U01 · FY2006 · AI

The East Africa Consortium for HPV and Cervical Cancer in Women living with HIV/AIDS

$926,411
Patrick J Loehrer · Indiana University Indianapolis · U54 · FY2024 · CA

Investigating the Protective Efficacy of SIV/HIV T and B cell Immunity Induced by RNA Replicons

$926,410
Gaurav Das Gaiha · Massachusetts General Hospital · R01 · FY2023 · AI

PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS

$926,226
Robert Lachance · Nh State Dept/Hlth Statistics/Data Mgmt · U62 · FY2013 · PS

The Effects of Prenatal Cocaine Exposure in Adolescence

$926,025
Sonia Minnes · Case Western Reserve University · R01 · FY2011 · DA

Immune correlates of tuberculosis and non-tuberculosis infectious morbidity in Southern African HIV-exposed, uninfected infants.

$925,915
Kathleen Powis · Massachusetts General Hospital · R01 · FY2022 · AI

Kaposi Sarcoma in the Era of ART in Africa Program (KEAAP)

$925,902
Charles Wood · Lsu Health Sciences Center · U54 · FY2024 · CA

TRUST

$925,773
William Albert Blattner · University Of Maryland Baltimore · R01 · FY2013 · MH